ResearcherAdventHealth TampaActive in the last 2 years
Sharona B Ross
Matched on ORCID iD 0000-0003-1056-3440; OpenAlex author ID A5006913734. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: 3 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 9
- Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 St… Co-author DOI 10.1200/jco-25-00746↗
- The Oncological Stress Test of Neoadjuvant Therapy: A Systematic Review in Outcomes of Neoadjuvant Therapy Compared to Upfront Resection Approach for Borderlin… Co-author DOI 10.1177/00031348241248703↗
- Has survival improved following resection for pancreatic adenocarcinoma? Co-author DOI 10.1016/j.amjsurg.2017.05.007↗
- Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma. First author DOI 10.1089/pancan.2017.0011↗
- Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. Co-author DOI 10.1097/ij9.0000000000000015↗
- Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer. Last author DOI 10.1016/j.cancergen.2016.08.001↗
- Can pancreatic cancer behavior be predicted based on computed tomography measurements of fat and muscle mass? Co-author DOI 10.1097/ij9.0000000000000004↗
- Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1177/000313481307900818↗
- Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who undergo distal pancreatectomy and splene… Co-author DOI 10.1007/s11605-011-1765-6↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alexander S. Rosemurgy · 7 shared papers, 2012–2024 · strength 0.66
- Paper The Oncological Stress Test of Neoadjuvant Therapy: A Systematic Review in Outcomes of Neoadjuvant Therapy Compared to … DOI 10.1177/00031348241248703↗
- Paper Has survival improved following resection for pancreatic adenocarcinoma? DOI 10.1016/j.amjsurg.2017.05.007↗
- Paper Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancrea… DOI 10.1089/pancan.2017.0011↗
- Kenneth Luberice · 5 shared papers, 2012–2017 · strength 0.32
- Paper Has survival improved following resection for pancreatic adenocarcinoma? DOI 10.1016/j.amjsurg.2017.05.007↗
- Paper Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. DOI 10.1097/ij9.0000000000000015↗
- Paper Can pancreatic cancer behavior be predicted based on computed tomography measurements of fat and muscle mass? DOI 10.1097/ij9.0000000000000004↗
- Iswanto Sucandy · 1 shared paper, 2024 · strength 0.26
- Paul G. Toomey · 3 shared papers, 2012–2017 · strength 0.16
- Paper Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma. DOI 10.1097/ij9.0000000000000015↗
- Paper Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1177/000313481307900818↗
- Paper Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who … DOI 10.1007/s11605-011-1765-6↗
- Ramtin Agah · 1 shared paper, 2017 · strength 0.08
- Indraneil Mukherjee · 1 shared paper, 2016 · strength 0.08
- Whalen Clark · 1 shared paper, 2016 · strength 0.07
- Jonathan Matthew Hernandez · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.